Literature DB >> 18577190

Papulopustular eruption after intravitreal bevacizumab (Avastin).

Luis Amselem, Manuel Diaz-Llopis, Salvador Garcia-Delpech, Javier Montero, Paula Palomares, Enrique Cervera.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18577190     DOI： 10.1111/j.1755-3768.2007.01154.x

Source DB:  PubMed          Journal:  Acta Ophthalmol        ISSN： 1755-375X            Impact factor:   3.761


× No keyword cloud information.
  5 in total

1.  An unusual case of allopurinol hypersensitivity syndrome potentiated by intravitreal bevacizumab.

Authors:  Biswa Mohan Padhy; Yogendra Kumar Gupta; Saravana Perumal Shanmugam; Naina Ranjit Bamrolia
Journal:  Eur J Clin Pharmacol       Date:  2010-11-11       Impact factor: 2.953

2.  Acneiform eruption in a patient receiving bevacizumab for glioblastoma multiforme.

Authors:  Bridget P Keenan; Rachel Abuav
Journal:  Arch Dermatol       Date:  2010-05

Review 3.  Off-label use of bevacizumab for the treatment of age-related macular degeneration: what is the evidence?

Authors:  Focke Ziemssen; Salvatore Grisanti; Karl Ulrich Bartz-Schmidt; Martin S Spitzer
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

4.  Quantifying the increasing use of anti-vascular endothelial growth factor therapy in ophthalmology.

Authors:  Jonathan A Micieli; Andrew Micieli
Journal:  Mcgill J Med       Date:  2011-06

5.  Cutaneous Cell-Mediated Delayed Hypersensitivity to Intravitreal Bevacizumab.

Authors:  Anthony Fam; Paul T Finger
Journal:  Middle East Afr J Ophthalmol       Date:  2020-10-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.